Correlation Between Caribou Biosciences and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Conduit Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and Conduit Pharmaceuticals
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Caribou and Conduit is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Conduit Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.22 times more return on investment than Conduit Pharmaceuticals. However, Caribou Biosciences is 4.46 times less risky than Conduit Pharmaceuticals. It trades about -0.28 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 237.00 in Caribou Biosciences on December 2, 2024 and sell it today you would lose (120.00) from holding Caribou Biosciences or give up 50.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Conduit Pharmaceuticals
Performance |
Timeline |
Caribou Biosciences |
Conduit Pharmaceuticals |
Caribou Biosciences and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Conduit Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Conduit Pharmaceuticals vs. Ballys Corp | Conduit Pharmaceuticals vs. Arcos Dorados Holdings | Conduit Pharmaceuticals vs. Paysafe | Conduit Pharmaceuticals vs. Sapiens International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |